| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/24/2004 | US20040120941 Administering oxalate-degrading microbes and oxalate-degrading enzymes to treat urolithiasis or kidney stones |
| 06/24/2004 | US20040120937 Transfusion of natural and/or artificial blood and/or plasma, while draining natural blood in poison and snake bite patients; leukemia, cancer, aging |
| 06/24/2004 | US20040120936 Enhanced composition for treatment of obesity |
| 06/24/2004 | US20040120935 Genetically modified yt cell line and use thereof |
| 06/24/2004 | US20040120934 Cloned ungulate embryos and animals, use of cells tissues and organs thereof for transplantation therapies including parkinson's disease |
| 06/24/2004 | US20040120931 Compositions having an inner core and at least two surrounding layers |
| 06/24/2004 | US20040120925 Administering substance capable of inducing and proliferating dendritic cells or inducing gene expression of nerve growth factors; brain or nervous system disorders |
| 06/24/2004 | CA2547899A1 Cell-based therapies for ischemia |
| 06/24/2004 | CA2509666A1 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin |
| 06/24/2004 | CA2508850A1 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 06/24/2004 | CA2507980A1 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/23/2004 | EP1430899A1 Graft from submucosal intestinal tissue for repairing neurological tissue |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430115A1 Immortilized stem cells |
| 06/23/2004 | EP1430114A2 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 06/23/2004 | EP1430113A2 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application |
| 06/23/2004 | EP1430111A1 Culture system for rapid expansion of human embryonic stem cells |
| 06/23/2004 | EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 06/23/2004 | EP1430067A2 Eukaryotic cells and method for preserving cells |
| 06/23/2004 | EP1429817A1 Porous ceramic composite bone grafts |
| 06/23/2004 | EP1429808A1 Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 06/23/2004 | EP1429802A1 Delivery system for biological component |
| 06/23/2004 | EP1429733A1 Preparation of microparticles |
| 06/23/2004 | EP1429710A1 Compositions, methods and apparatus for surgical procedures |
| 06/23/2004 | EP1265985A4 Pancreatic islet cell growth factors |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP1121948B1 Device and methods for perfusing peritoneal dialysing fluid |
| 06/23/2004 | EP1089767B1 Method of inactivating viruses |
| 06/23/2004 | EP1071438B1 Stabilised herpesvirus preparation |
| 06/23/2004 | EP0750505B1 Immunotherapy of cancer with allogeneic lymphocytes |
| 06/23/2004 | CN1507358A Carrier with solid fibrinogen and solid thrombin |
| 06/23/2004 | CN1507353A Compositions for use in treating IGE-associated disorders |
| 06/23/2004 | CN1506102A Toxin expelling and face nursing aloe capsule and its making process |
| 06/23/2004 | CN1506075A Cell growth regulating factor V and its prepn process |
| 06/23/2004 | CN1506063A Cell growth regulatnig factor F and its prepn process |
| 06/23/2004 | CN1506062A Cell growth regulating factor G and its prepn process |
| 06/23/2004 | CN1506061A Cell growth regulating factor II and its prepn process |
| 06/23/2004 | CN1506060A Cell growth regulating factor I and its prepn process |
| 06/23/2004 | CN1506042A Method and composition for improving skin state using compound from fetal cell and tissue |
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154717C Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof |
| 06/23/2004 | CN1154506C Method of preventing or treating allergies |
| 06/23/2004 | CN1154504C Lingguo extract capsule and its prepn. method |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/22/2004 | US6753315 Locally administering to a cutaneous tissue an isolated native or modified alpha -bungarotoxin molecule (a polypeptide) to enhance denervation of the muscle to enhance relaxation or slackening of the cutaneous tissue |
| 06/22/2004 | US6753162 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 06/22/2004 | US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors |
| 06/22/2004 | CA2194270C Method and system for cultivating cells particularly macrophages |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/17/2004 | WO2004050865A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 06/17/2004 | WO2004050832A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050208A1 Method of extract composition control in peat extraction, peat extract, and use of peat extract |
| 06/17/2004 | WO2004050121A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 06/17/2004 | WO2004050105A1 An anti-arrhythmic compound from king cobra venom and a process of purification thereof |
| 06/17/2004 | WO2004050103A1 Replacement joint fluid |
| 06/17/2004 | WO2004050078A1 Remedy |
| 06/17/2004 | WO2004050013A2 Material compositions and related systems and methods for treating cardiac conditions |
| 06/17/2004 | WO2004049830A1 Sustained improver of muscular fatigue |
| 06/17/2004 | WO2004034989A9 Probiotic bacteria |
| 06/17/2004 | WO2004018002A3 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 06/17/2004 | WO2004015077A9 Compositions and methods for neural differentiation of embryonic stem cells |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003068357A3 Identification and high-yield isolation of human pancreatic islet progenitor and stem cells |
| 06/17/2004 | WO2003066072A3 Cell therapy using immunoregulatory t-cells |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | US20040117033 Method for composite cell-based implants |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116032 Electroprocessed collagen |
| 06/17/2004 | US20040115809 Propagating cytotoxic lymphocytes with specific toxicity in the presence of antigen presenting cells for use in treatment of tumors and viral infections; immunotherapy |
| 06/17/2004 | US20040115808 In vitro neuronal stem cell culture for transplantation and treatment of neurodegenerative and gastrointestinal diseases; tissue engineering |
| 06/17/2004 | US20040115807 O-2a progenitors multipotent cells from neurohypophysis |
| 06/17/2004 | US20040115805 CD56 positive human adult pancreatic endocrine progenitor cells |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115622 Mixture of peptides originating from a Nef protein and applications thereof |
| 06/17/2004 | US20040115612 Monochromatic fluid treatment systems |
| 06/17/2004 | US20040115331 Suitable for inclusion in food |
| 06/17/2004 | US20040115243 Compositions for oral delivery of nutrients and pharmaceuticals |
| 06/17/2004 | US20040115238 Muscle-polymer constructs for bone tissue engineering |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |
| 06/17/2004 | US20040115179 treating and preventing gastrointestinal diseases as well as lowering serum cholesterol |
| 06/17/2004 | US20040115178 hydrophobic surface |
| 06/17/2004 | US20040115177 Probiotic compositions and methods against bacterial infection in livestock animals |
| 06/17/2004 | US20040115175 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 06/17/2004 | US20040115173 Method of treating inflammation, particularly diabetes |
| 06/17/2004 | US20040115170 reducing viability of a tumor cell by administering a non-naturally occuring reovirus expressing a particular mu-2 protein or a virus capable of expressing the reovirus mu-2 protein |
| 06/17/2004 | US20040115139 Botulinum toxin dental therapies and procedures |
| 06/17/2004 | DE10255217A1 Homeopathic medicament for treating mental suffering conditions, e.g. grief, comprising tears subjected to homeopathic dilution and incorporated in dosage form |
| 06/17/2004 | CA2508309A1 Remedy |
| 06/17/2004 | CA2507395A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 06/17/2004 | CA2504801A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 06/17/2004 | CA2503973A1 Material compositions and related systems and methods for treating cardiac conditions |
| 06/16/2004 | EP1428872A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ |
| 06/16/2004 | EP1428540A1 Tissue regenerative composition |